Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Acta Crystallographica. Section E, Structure Reports Online
|
May 19, 2012
4-(4-Nitro-phen-yl)morpholine
Li-Jiao Wang, Wei-Wei Li, Sheng-Yong Yang, et al.
Medicine
|
February 13, 2026
The relationship between intake of dietary omega-3 and omega-6 fatty acids and sleep quality in older adults with diabetes: A hospital-based analysis
Li-Jiao Wang, Yu-Ping Shen, Man-Fei Xu, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion
|
October 10, 2021
[Clinical observation on deep needling at Xiaguan (ST 7) with round sharp needle combined with plum-blossom needle for trigeminal neuralgia of wind and heat]
Min-Min Wu, Xiao-Hua Liu, Li-Jiao Wang, et al.
Oncology Letters
|
September 26, 2018
Src kinase inhibitor PP2 regulates the biological characteristics of A549 cells via the PI3K/Akt signaling pathway
Xi Dai, Li-Jiao Wang, Juan Wu, et al.
Nanotechnology
|
May 7, 2009
Synthesis and enhanced ethanol sensing characteristics of alpha-Fe2O3/SnO2 core-shell nanorods
Yu-Jin Chen, Chun-Ling Zhu, Li-Jiao Wang, et al.
Journal of Medicinal Chemistry
|
February 1, 2013
Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo
Ling-Ling Yang, Guo-Bo Li, Shuang Ma, et al.
Bioorganic & Medicinal Chemistry
|
November 2, 2025
Design, synthesis and biological evaluation of novel glutaminyl cyclase inhibitors targeting the CD47-SIRPα axis in breast cancer cells
Rong Li, Wei-Feng Zhang, Hui Lei, et al.
Journal of Medicinal Chemistry
|
November 3, 2012
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations
Jiao Yang, Li-Jiao Wang, Jing-Jing Liu, et al.
Journal of Medicinal Chemistry
|
August 19, 2016
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model
Guo-Bo Li, Shuang Ma, Ling-Ling Yang, et al.
Journal of Medicinal Chemistry
|
March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo
Wei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Acta Crystallographica. Section E, Structure Reports Online
|
May 19, 2012
4-(4-Nitro-phen-yl)morpholine
Li-Jiao Wang, Wei-Wei Li, Sheng-Yong Yang, et al.
Medicine
|
February 13, 2026
The relationship between intake of dietary omega-3 and omega-6 fatty acids and sleep quality in older adults with diabetes: A hospital-based analysis
Li-Jiao Wang, Yu-Ping Shen, Man-Fei Xu, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion
|
October 10, 2021
[Clinical observation on deep needling at Xiaguan (ST 7) with round sharp needle combined with plum-blossom needle for trigeminal neuralgia of wind and heat]
Min-Min Wu, Xiao-Hua Liu, Li-Jiao Wang, et al.
Oncology Letters
|
September 26, 2018
Src kinase inhibitor PP2 regulates the biological characteristics of A549 cells via the PI3K/Akt signaling pathway
Xi Dai, Li-Jiao Wang, Juan Wu, et al.
Nanotechnology
|
May 7, 2009
Synthesis and enhanced ethanol sensing characteristics of alpha-Fe2O3/SnO2 core-shell nanorods
Yu-Jin Chen, Chun-Ling Zhu, Li-Jiao Wang, et al.
Journal of Medicinal Chemistry
|
February 1, 2013
Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo
Ling-Ling Yang, Guo-Bo Li, Shuang Ma, et al.
Bioorganic & Medicinal Chemistry
|
November 2, 2025
Design, synthesis and biological evaluation of novel glutaminyl cyclase inhibitors targeting the CD47-SIRPα axis in breast cancer cells
Rong Li, Wei-Feng Zhang, Hui Lei, et al.
Journal of Medicinal Chemistry
|
November 3, 2012
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations
Jiao Yang, Li-Jiao Wang, Jing-Jing Liu, et al.
Journal of Medicinal Chemistry
|
August 19, 2016
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model
Guo-Bo Li, Shuang Ma, Ling-Ling Yang, et al.
Journal of Medicinal Chemistry
|
March 29, 2012
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo
Wei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.
Page
of 1